984PClinical outcomes according to age and comorbidities in the OSCAR UK observational study of front-line bevacizumab (BEV)-containing therapy for advanced ovarian cancer (aOC). (23rd October 2018) - Hall, M; Bertelli, G; Li, L; Green, C; Chan, S; Yeoh, C C; Hasan, J; Ograbek, A; Perren, T J